Sirolimus
3 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Sirolimus for arteriovenous malformations | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Sirolimus for corneal dystrophies, hereditary | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Sirolimus for endometrial neoplasms | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |